Risk of tuberculosis from arthritis medication examined
Tuesday, June 30, 2009 - 17:42
in Health & Medicine
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's disease, psoriatic arthritis and psoriasis. Most TB cases develop as a result of reactivation of a latent TB infection, and health authorities worldwide recommend screening for latent TB and treating patients before initiating anti-TNF treatment.
Read the whole article on Physorg
More from Physorg
Related
- Risk of tuberculosis from arthritis medication examinedTue, 30 Jun 2009, 18:42:30 EDT
- New drug shows promising results for psoriatic arthritisTue, 7 Apr 2009, 13:29:37 EDT
- Anti-tumor necrosis factor treatment does not increase cancer Risk in RA patientsThu, 29 Oct 2009, 1:23:53 EDT
- Adalimumab therapy effective in AS, RA and PsA patients refractory to other anti-TNF therapiesThu, 12 Jun 2008, 10:36:26 EDT
- CV risk management should be mandatory in RA and other types of inflammatory rheumatic diseaseFri, 13 Jun 2008, 14:23:25 EDT